Wencong Liu

Wencong Liu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2020 in PeerJ
Verified
Journal Article
Open access
MHMingqian Hao
Mingqian Hao
WLWencong Liu
Wencong Liu
CDChuanbo Ding
Chuanbo Ding
XPXiaojuan Peng
Xiaojuan Peng
YZYue Zhang
Yue Zhang
YZYinan Zheng
Yinan Zheng
Breast cancer is one of the most common malignant tumors among women worldwide and has a high morbidity and mortality. This research aimed to identify hub genes and small molecule drugs for breast cancer by integrated bioinformatics analysis. After downloading multiple gene expression datasets from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database, 283 overlapping differentially expressed genes (DEGs) significantly enriched in different cancer-related functions and pathways were obtained using LIMMA, VennDiagram and ClusterProfiler packages of R. We then analyzed the topology of protein–protein interaction (PPI) network with overlapping DEGs and further obtained six hub genes (RRM2, CDC20, CCNB2, BUB1B, CDK1, and CCNA2) from the network via STRING and Cytoscape. Subsequently, we conducted genes expression verification, genetic alterations evaluation, immune infiltration prediction, clinicopathological parameters analysis, identification of transcriptional and post-transcriptional regulatory molecules, and survival analysis for these hub genes. Meanwhile, 29 possible drug candidates (e.g., Cladribine, Gallium nitrate, Alvocidib, 1β-hydroxyalantolactone, Berberine hydrochloride, Nitidine chloride) were identified from the DGIdb database and the GSE85871 dataset. In addition, some transcription factors and miRNAs (e.g., E2F1, PTTG1, TP53, ZBTB16, hsa-miR-130a-3p, hsa-miR-204-5p) targeting hub genes were identified as key regulators in the progression of breast cancer. In conclusion, our study identified six hub genes and 29 potential drug candidates for breast cancer. These findings may advance understanding regarding the diagnosis, prognosis and treatment of breast cancer.

1 January 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
XCXueyan Chen
Xueyan Chen
CDChuanbo Ding
Chuanbo Ding
WLWencong Liu
Wencong Liu
WLWencong Liu
Wencong Liu
YZYingchun Zhao
Yingchun Zhao
HCHuiying Chen
Huiying Chen

11 May 2023 in BIO Web of Conferences
Verified
Journal Article
Open access
PDF file
MYMin Yang
Min Yang
CDChuanbo Ding
Chuanbo Ding
WLWencong Liu
Wencong Liu
JFJihao Fang
Jihao Fang
Functional nanofibers have good porosity to exchange oxygen and appropriate surface hydrophilicity to promote cell adhesion and proliferation, which has attracted extensive attention in the medical research field in the treatment of skin repair diseases. Puerarin is a kind of isoflavones extracted from the roots of the leguminous plant pueraria lobata or kudzu vine. Because of its strong antioxidant, free radical scavenging and anti-tumor effects, puerarin has made some preliminary exploration in the research field of skin diseases in recent years. This paper summarizes the research progress of skin wound repair, puerarin treatment of skin diseases and nanotechnology in skin wound repair, with a view to providing new therapeutic ideas for the research and development of puerarin skin wound repair.